Hepatitis B virus acquisition and pathogenesis in childhood: Host genetic determinants

Journal of Pediatric Gastroenterology and Nutrition

Volumn 52, Issue 1, 2011, Pages 3-8

  Chatzidaki, V ^a   Kouroumalis, E ^b   Galanakis, E ^a,b  

^a Department of Paediatrics ^*  (Greece)

^b UNIVERSITY OF CRETE   (Greece)

Author keywords

childhood; gene polymorphisms; HBV; susceptibility

Indexed keywords

HLA ANTIGEN;

CELLULAR IMMUNITY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; GENETIC MARKER; GENETIC SCREENING; GENETICS; HEPATITIS B; HEPATITIS B VIRUS; HEREDITY; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS CELL INTERACTION; VIRUS PATHOGENESIS;

CHEMOKINES; CHILD; CHILD, PRESCHOOL; CYTOKINES; GENETIC PREDISPOSITION TO DISEASE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, INNATE; IMMUNOLOGIC FACTORS;

HEPATITIS B VIRUS;

EID: 78650950358     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3181fb0cb9     Document Type: Review

References (71)

1. Lavanchy D. Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J Clin Virol 2006;34:S1-3.
2. European Association for the Study of the Liver. EASL Clinical practice guidelines: management of chronic hepatitis B. J Hepatol 2009;50: 227-42.
3. World Health Organization. Hepatitis B. hepatitis/whocdscsrlyo20022/en/. Accessed November 4, 2010.
4. Hann HW, Kim CY, London T, et al. Hepatitits B virus and primary hepatocellular carcinoma: family studies in Korea. Int J Cancer 1982; 30:47-51.
5. Lin TM, Chen CJ, Wu MM, et al. Hepatitis B virus markers in Chinese twins. Anticancer Res 1989;9:737-41.
6. Tong MJ, Weiner JM, Ashcavai MW, et al. A comparative study of hepatitis B viral markers in the family members of Asian and non-Asian patients with hepatitis B surface antigen-positive hepatocellular carcinoma and with chronic hepatitis B infection. J Infect Dis 1979;140:506-12.
7. Ying LH, Ying RZ, Shu LZ, et al. Host susceptibility to persistent hepatitis B virus infection. World J Gastroenterol 2006;12:4788-93.
8. Demir G, Belentepe S, Ozguroglu M, et al. Simultaneous presentation of hepatocellular carcinoma in identical twin brothers. Med Oncol 2002; 19:113-6.
9. Lin J, Liu KY. Linkage and association analyses of microsatellites and single-nucleotide polymorphisms in nuclear families. BMC Genet 2005;6 (S25):1-5.
10. Hirschhorn JN, Daly MJ. Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 2005;6:95-108.
11. Koch A, Melbye M, Sørensen P, et al. Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood. JAMA 2001;285:1316-21.
12. Boniotto M, Crovella S, Pirulli D, et al. MBL2 polymorphisms are involved in HIV-1 infection in Brazilian perinatally infected children. AIDS 2003;17:779-80.
13. HibberdML, Sumiya M, Summerfield JA, et al. Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease. Meningococcal Research Group. Lancet 1999;353:1049-53.
14. Chong WP, To YF, Ip WK, et al. Mannose binding lectin in hepatitis B virus infection. Hepatology 2005;42:1037-45.
15. Fraser D, Bohlson A, Jasinskiene N, et al. C1q and MBL, components of the innate immune system, influence monocyte cytokine expression. J Leukoc Biol 2006;80:107-16.
16. Brown K, Ryder S, Irving W, et al. Mannan binding lectin and viral hepatitis. Immunol Lett 2006;108:34-44.
17. Bevilacqua E, Fabris A, Floreano P, et al. Genetic factors in mother-tochild transmission of HCV infection. Virology 2009;390:64-70.
18. Safioleas M, Lygidakis NJ, Manti C. Hepatitis B today. Hepatogastroenterology 2007;54:545-8.
19. Chang J, Lewin S. Immunopathogenesis of hepatitis B virus infection. Immunol Cell Biol 2007;85:16-23.
20. Thursz MR, Kwiatkowski D, Allsopp CE, et al. Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med 1995;332:1065-9.
21. Martin MP, Carrington M. Immunogenetics of viral infections. Curr Opin Immunol 2005;17:510-6.
22. Singh R, Kaul R, Kaul A, et al. A comparative review of HLA associations with hepatitis B and C viral infections across global populations. World J Gastroenterol 2007;13:1770-87.
23. Liu HY, Kong BH, Luo X, et al. Study on the association between maternal-infantile vertical transmission of hepatitis B virus and human leukocyte antigen DR gene domain [abstract]. Zhonghua Fu Chan Ke Za Zhi 2003;38:599-603.
24. Xu YY, Yu J, Zhong Y, et al. Association between the frequency of class II HLA antigens and the susceptibility to intrauterine infection of hepatitis B virus. Int J Biol Sci 2008;4:111-5.
25. Pestka S, Krause CD,Walter MR. Interferons, interferon-like cytokines, and their receptors. Immunol Rev 2004;202:8-32.
26. Frodsham AJ, Zhang L, Dumpis U, et al. Class II cytokine receptor gene cluster is a major locus for hepatitis B persistence. Proc Natl Acad Sci U S A 2006;103:9148-53.
27. Lee WM. Hepatitis B virus infection. N Engl J Med 1997;337:1733-45.
28. Zhou J, Smith DK, Lu L, et al. A non-synonymous single nucleotide polymorphism in IFNAR1 affects susceptibility to chronic hepatitis B virus infection. J Viral Hepat 2009;16:45-52.
29. Pravica V, Asderakis A, Perrey C, et al. In vitro production of IFNgamma correlates with CA repeat polymorphism in the human IFNgamma gene. Eur J Immunogenet 1999;26:1-3.
30. Pravica V, Perrey C, Stevens A, et al. A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum Immunol 2000;61:863-6.
31. Abbott W, Gane E, Winship I, et al. Polymorphism in intron 1 of the interferon-gamma gene influences both serum immunoglobulin E levels and the risk for chronic hepatitis B virus infection in Polynesians. Immunogenetics 2007;59:187-95.
32. Yu H, Zhu QR, Gu SQ, et al. Association of interferon-gamma 874 gene single nucleotide polymorphism with susceptibility to intrauterine HBV infection [abstract]. Zhonghua Er Ke Za Zhi 2004;42:421-3.
33. Yu H, Zhu QR, Gu SQ, et al. Relationship between IFN-gamma gene polymorphism and susceptibility to intrauterine HBVinfection. World J Gastroenterol 2006;12:2928-31.
34. Cheong JY, Cho SW, Hwang IL, et al. Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factoralpha gene promoter polymorphisms. J Gastroenterol Hepatol 2006;7: 1163-9.
35. Niro GA, Fontana R, Gioffreda D, et al. Tumor necrosis factor gene polymorphisms and clearance or progression of hepatitis B virus infection. Liver Int 2005;25:1175-81.
36. Du T, Guo XH, Zhu XL, et al. Association of TNF-alpha promoter polymorphisms with the outcomes of hepatitis B virus infection in Chinese Han population. J Viral Hepat 2006;9:618-24.
37. Gu SQ, Zhu QR, Yu H, et al. Relationship between genetic polymorphism of tumor necrosis factor-alpha and susceptibility to intrauterine HBV infection [abstract]. Zhonghua Gan Zang Bing Za Zhi 2004;12: 538-9.
38. Zhu QR, Ge YL, Gu SQ, et al. Relationship between cytokines gene polymorphism and susceptibility to hepatitis B virus intrauterine infection. Chin Med J 2005;118:1604-9.
39. Ahn SH, Kim DY, Chang HY, et al. Association of genetic variations in CCR5 and its ligand, RANTES with clearance of hepatitis B virus in Korea. J Med Virol 2006;78:1564-71.
40. Pedersen B, Kamwendo D, Blood M, et al. CCR5 haplotypes and mother-to-child HIV transmission in Malawi. PLoS One 2007;2:e838.
41. Liu M, Cao B, Zhang H, et al. Association of interferon-gamma gene haplotype in the Chinese population with hepatitis B virus infection. Immunogenetics 2006;58:859-64.
42. Shan J, Wang L, Li Z, et al. Relationship between polymorphisms of vitamin D receptor gene and familial aggregation of HBsAg carriers [abstract]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2006;28:148-53.
43. Park TJ, Chun JC, Bae JS. CCND2 polymorphisms associated wth clearance of HBV infection. J Hum Genet 2010;55:416-20.
44. Craxi A, Montano L, Goodall A, et al. Genetic and sex-linked factors influencing HBs antigen clearance: non-immune clearance in inbred strains of mice. J Med Virol 1982;9:117-21.
45. Deng G, Zhou G, Zhai Y, et al. Association of estrogen receptor polymorphisms with susceptibility to chronic hepatitis B virus infection. Hepatology 2004;40:318-26.
46. Hohler T, Reuss E, Evers N, et al. Differential genetic determination of immune responsiveness to hepatitis B surface antigen and to hepatitis A virus: a vaccination study in twins. Lancet 2002;360:991-5.
47. Kimman TG, Vandebriel RJ, Hoebee B. Genetic variation in the response to vaccination. Community Genet 2007;10:201-17.
48. Martinetti M, De Silvestri A, Belloni C, et al. Humoral response to recombinant hepatitis B virus vaccine at birth: role of HLA and beyond. Clin Immunol 2000;97:234-40.
49. Wang C, Tang J, SongW, et al. HLA and cytokine gene polymorphisms are independently associated with responses to hepatitis B vaccination. Hepatology 2004;39:978-88.
50. Deulofeut H, Iglesias A, Mikael N, et al. Cellular recognition and HLA restriction of a midsequence HBsAg peptide in hepatitis B vaccinated individuals. Mol Immunol 1993;30:941-8.
51. Hennig BJ, Fielding K, Broxholme J, et al. Host genetic factors and vaccine-induced immunity to hepatitis B virus infection. PLos One 2008;3:e1898.
52. Shirak K. Perinatal transmission of hepatitis B virus and its prevention. J Gastroenterol Hepatol 2000;15:E11-15.
53. Azzari C, Resti M, Rossi ME, et al. Modulation of human milk of IgG subclass response to hepatitis B vaccine in infants. J Pediatr Gastroenterol Nutr 1990;10:310-5.
54. Vajro P, Fontanella A. Breast feeding and hepatitis B. J Pediatr Gastroenterol Nutr 1991;12:141.
55. Nemes E, Lefler E, Szegedi L, et al. Gluten intake with the humoral immune response to recombinant hepatitis B vaccine in patients with celiac disease. Paediatrics 2008;121:1570-6.
56. Wang FS. Current status and prospects of studies on human genetic alleles associated with hepatitis B virus infection.World J Gastroenterol 2003;9:641-4.
57. Li JH, Li HQ, Li Z, et al. Association of Taq I T/C and Fok I C/T polymorphisms of vitamin D receptor gene with outcome of hepatitis B virus infection. [abstract]. Zhonghua Yi Xue Za Zhi 2006;86:1952-6.
58. Poland G, Ovsyannikova I, Jacobson R. Personalized vaccines: the emerging field of vaccinomics. Expert Opin Biol Therapy 2008;8:1659-67.
59. Thomas D, Thio C, Martin M. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 2009;461:798-802.
60. Rauch A, Kutalik Z, Descombes P, et al. Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: A genome wide association study. Gastroenterology 2010;138:1338-45.
61. Caillat-Zucman S, Gimenez JJ, Wambergue F, et al. Distinct HLA class II alleles determine antibody response to vaccination with hepatitis B surface antigen. Kidney Int 1998;53:1626-30.
62. Karan MA, Tassioglou NE, Ozturk AO, et al. The role of HLA antigens in chronic hepatitis B virus infection. J Pak Med Assoc 2002;52:253-6.
63. Zhu XL, Du T, Li JH, et al. Association of HLA-DQB1 gene polymorphisms with outcome of HBV infection in a Chinese Han population. Swiss Med Wkly 2007;137:114-20.
64. Amarapurpar DN, Patel ND, Kankonkar SR. HLA class IIgenotyping in chronic hepatitis B infection. J Assoc Phys India 2003;51:779-81.
65. Ahn SH, Han KH, Park JY, et al. Association between hepatitis B virus infection and HLA-DR type in Korea. Hepatology 2000;31:1371-3.
66. Cotrina M, Buti M, Jardi R, et al. Study of HLA-II antigens in chronic hepatitis C and B and in acute hepatitis B. Gastroenterol Hepatol 1997;20:115-8.
67. Hohler T, Gerken G, Notghi A, et al. HLA-DRB1-1301 and-1302 protect against chronic hepatitis B. J Hepatol 1997;26:503-7.
68. Diepolder HM, Jung MC, Keller E, et al. A vigorous virus-specific CD4 T cell response may contribute to the association of HLA-DR13 with viral clearance in hepatitis B. Clin Exp Immunol 1998;113:244-51.
69. Desombere I, Willems A, Leroux-Roels G. Response to hepatitis B vaccine: multiple HLA genes are involved. Tissue Antigens 1998;51: 593-604.
70. Popov EA, Levitan BN, Alekseev LP, et al. Immunogenetic HLA markers of chronic viral hepatitis. Ter Arkh 2005;77:54-9.
71. Thio CL, Thomas DL, Karacki P, et al. Comprehensive analysis of class I and class II HLA antigens and chronic hepatitis B virus infection. J Virol 2003;77:12083-7.